The heart and lung are critical organs for life, but they’re also incredibly delicate.

Without adequate oxygen and oxygen-rich blood, your heart can’t pump blood properly and your lungs can’t breathe properly.

These problems can result in heart attacks and strokes.

If left untreated, they can lead to death.

The lungs are particularly vulnerable to disease.

Without oxygen, lung tissue cannot survive and can’t produce oxygen.

Without it, the body’s immune system can’t function properly, and this can lead quickly to pneumonia and other respiratory problems.

Without a proper oxygen supply, a lung can’t provide sufficient blood supply to the body and the lungs can die.

To help reduce the risk of these complications, heart disease researchers at University of California San Diego and Mayo Clinic researchers teamed up to develop a new way to treat heart failure.

The new technology uses a new kind of nanoparticle that can be placed in a patient’s blood vessels, and then injected into the heart.

The nanoparticle can be delivered via a thin tube, or it can be injected directly into the bloodstream.

The nanoparticles have two components: a small piece of DNA, and a molecule of oxygen that is added to the DNA.

When the nanoparticle is injected into a patient, it is transported to the heart’s blood supply.

Once there, the nanoparticles are chemically bonded to the blood vessel and delivered to the lungs.

The two nanoparticles then interact with the blood vessels to cause a chemical reaction that causes the cells to grow, and the heart muscle to contract, releasing the oxygen.

“The heart has a very intricate, very intricate structure that allows for the delivery of oxygen and nutrients and oxygen to the cells,” says Mayo Clinic Professor Dr. Robert Siegel.

“It’s very, very complicated, but it’s really, really important.”

Siegel and his colleagues believe that a nanoparticle may also help prevent and treat some other heart diseases, including high blood pressure and high cholesterol.

The new technology was published in the journal ACS Nano.

More information about heart failure is available at: